LMTK2: Difference between revisions
CSV import |
CSV import |
||
| (One intermediate revision by the same user not shown) | |||
| Line 36: | Line 36: | ||
{{gene-stub}} | {{gene-stub}} | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | |||
__NOINDEX__ | |||
Latest revision as of 17:14, 17 March 2025
LMTK2 (Lemur Tyrosine Kinase 2) is a protein that in humans is encoded by the LMTK2 gene. It is a member of the tyrosine kinase family of enzymes, which play a crucial role in cell signaling pathways and have been implicated in a variety of diseases, including cancer and neurodegenerative diseases.
Function[edit]
LMTK2 is a transmembrane protein that is primarily located in the endoplasmic reticulum and Golgi apparatus. It is involved in several cellular processes, including the regulation of endocytosis, cell proliferation, and apoptosis. LMTK2 also plays a role in the regulation of axon growth and neurite outgrowth in neurons.
Clinical significance[edit]
Alterations in the LMTK2 gene have been associated with a variety of diseases. For example, mutations in LMTK2 have been linked to prostate cancer, breast cancer, and lung cancer. In addition, LMTK2 has been implicated in Alzheimer's disease and Parkinson's disease, as it is involved in the regulation of tau protein and amyloid precursor protein.
Research[edit]
Research into LMTK2 is ongoing, with studies focusing on its role in cancer and neurodegenerative diseases. Understanding the function of LMTK2 and its role in disease could lead to the development of new therapeutic strategies.
See also[edit]
- Tyrosine kinase
- Endocytosis
- Cell proliferation
- Apoptosis
- Neuron
- Prostate cancer
- Breast cancer
- Lung cancer
- Alzheimer's disease
- Parkinson's disease


